AzTrials
AzTrials

Primary Headache DisorderNCT05057533

Primary Headaches and Irritable Bowel Syndrome.

An observational study of Primary Headache Disorder, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To assess the relationship between primary headaches and irritable bowel syndrome Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Primary Headache Disorder
What is being tested?
a questionnaire based on Rome IV Diagnostic criteria of IBS
Type of treatment
Injection or infusion
How many people
197 participants
Where
1 siteEgypt
Study dates
1 Jan 2022to 1 Feb 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: A group of patients attending headache outpatient clinic of Assuit University hospital diagnosed with primary headaches (migraine , tension Headache or cluster headache)according to a questionnaire based on diagnostic criteria established by the International Headache Society will interviewed with a questionnaire based on Rome IV Diagnostic criteria of IBS to detect the prevalence of IBS among patients with primary headaches

Who may be able to join

  • age more than 18.
  • both sex.
  • history suggestive of any type of primary headaches.
  • accept to participate in the study.

Who cannot join

  • Intake of medications that can aggravate Headache or IBS.
  • Presence of neurological disease other than primary headaches.
  • Presence of gastrointestinal disease other than IBS.

Trial locations and contacts

1 site in 1 country.

Mohamed Helmy, Resident doctor contact

+201018517954

Mohamedgamahelmy@gmail.com

Wafaa Fargaly, MD prof contact

+201000104904

Wafmaf2002@yahoo.com

Egypt1 site
  • Assiut University hospital

    Asyut

    Mohamed Helmy, Resident doctor, +201018517954, Mohamedgamahelmy@gmail.com

    Reda Badry, MD prof, +01008336450, redaalbady@yahoo.com

Other trials in Egypt

About this study

Official title: Association Between Primary Headaches and Irritable Bowel Syndrome.

To assess the relationship between primary headaches and irritable bowel syndrome

Read the detailed description

The association between primary headaches and functional gastrointestinal disorders has been confirmed by many clinical observations. In most patients during the attacks of headache, apart from various neurological and vascular symptoms, gastrointestinal disturbances occur . Functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), are reported in primary headache patients in periods between the attacks as well. On the other hand 23-53% of IBS patients have frequent headaches.

Migraine typically presents relapsing episodes of symptoms including headache, nausea, vomiting, sensory hypersensitivity and mood changes that last for hours to days . Similar to migraine, IBS is characterized by recurrent abdominal pain or discomfort with altered gastrointestinal motility and visceral hypersensitivity that returns to normal between attacks . Both pain disorders lack detectable organic causes .

An emerging model of the brain-gut axis was proposed to explain migraine and IBS as a result of a genetically sensitive nervous system that develops hyperexcitability over time as a response to multiple environmental and immunological factors.

Cluster headache (CH) characterized by its distinctive circadian and circannual periodicity, implicating the role of the hypothalamus in its underlying pathophysiology. CH and IBS are featuring recurrent attacks of pain that possess relationships with circadian rhythms and potentially hypothalamic derangements.

Tension headache that's associated with pain in head described as feeling like a tight band around head, also show many similarities with IBS such causes for both are unknown, and some studies suggest a possible link that could shed light on shared genetics of both condition .

Being tested
a questionnaire based on Rome IV Diagnostic criteria of IBS
Medical subject headings
Headache Disorders, Primary

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • a questionnaire based on Rome IV Diagnostic criteria of IBSOther

    The Rome IV criteria for the diagnosis of IBS require that patients have had recurrent abdominal pain on average at least 1 day per week during the previous 3 months that is associated with two or more of the following

    1. Related to defecation (may be increased or unchanged by defecation)
    2. Associated with a change in stool frequency
    3. Associated with a change in stool form or appearance The Rome IV criteria (May 2016) only require abdominal pain in defining this condition; "discomfort" is no longer a requirement owing to its nonspecificity, and the recurrent abdominal pain. [2] Supporting symptoms include the following:Altered stool frequency Altered stool form Altered stool passage (straining and/or urgency) Mucorrhea Abdominal bloating or subjective distention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association between primary headaches and irritable bowel syndrome

    To Detect the prevalence of IBS among patients with primary headaches

    Measured: Basline

Secondary outcomes (1)
  1. Subtypes of primary headachecs and IBS

    Detect the intimate correlation between each type of primary headaches and IBS

    Measured: Basline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Sep 2021
  2. Study start1 Jan 2022 (estimated)
  3. Primary completion1 Jan 2022 (estimated)
  4. Study completion1 Feb 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
197 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05057533
Sponsor's protocol ID
Primary Headaches and IBS
Status last verified
Sep 2021
First submitted
16 Sep 2021
Last updated
29 Sep 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Soares RL, Moreira-Filho PF, Maneschy CP, Breijao JF, Schmidte NM. The prevalence and clinical characteristics of primary headache in irritable bowel syndrome: a subgroup of the functional somatic syndromes. Arq Gastroenterol. 2013 Oct-Dec;50(4):281-4. doi: 10.1590/S0004-28032013000400008.

    PubMed 24474230
  • Martami F, Ghorbani Z, Abolhasani M, Togha M, Meysamie A, Sharifi A, Razeghi Jahromi S. Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran. Neurol Sci. 2018 Jan;39(1):63-70. doi: 10.1007/s10072-017-3141-0. Epub 2017 Oct 11.

    PubMed 29022143
  • Doulberis M, Saleh C, Beyenburg S. Is there an Association between Migraine and Gastrointestinal Disorders? J Clin Neurol. 2017 Jul;13(3):215-226. doi: 10.3988/jcn.2017.13.3.215.

    PubMed 28748672

Questions about this trial

What is this clinical trial studying?

An observational study of Primary Headache Disorder, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed Helmy, Resident doctor (+201018517954, Mohamedgamahelmy@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association between primary headaches and irritable bowel syndrome (time frame: Basline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05057533, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in